Pliant Therapeutics, Inc. (PLRX)
1.165
-0.02
(-2.10%)
USD |
NASDAQ |
Aug 26, 16:00
1.15
-0.02
(-1.29%)
After-Hours: 20:00
Pliant Therapeutics EPS Diluted (Quarterly) : -0.3613 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3613 |
| March 31, 2026 | -0.3242 |
| December 31, 2025 | -0.3837 |
| September 30, 2025 | -0.4283 |
| June 30, 2025 | -0.7054 |
| March 31, 2025 | -0.9174 |
| December 31, 2024 | -0.8172 |
| September 30, 2024 | -0.9511 |
| June 30, 2024 | -0.925 |
| March 31, 2024 | -0.7802 |
| December 31, 2023 | -0.6862 |
| September 30, 2023 | -0.6951 |
| June 30, 2023 | -0.6961 |
| March 31, 2023 | -0.6698 |
| December 31, 2022 | -0.7187 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.6542 |
| June 30, 2022 | -0.8168 |
| March 31, 2022 | -0.778 |
| December 31, 2021 | -0.681 |
| September 30, 2021 | -0.7532 |
| June 30, 2021 | -0.6387 |
| March 31, 2021 | -0.6412 |
| December 31, 2020 | -0.5352 |
| September 30, 2020 | -0.4665 |
| June 30, 2020 | -1.387 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 1.126 |
| September 30, 2019 | -8.534 |
| June 30, 2019 | -10.82 |
| March 31, 2019 | -0.4322 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.1781 |
| CorMedix, Inc. | 0.281 |
| Eloxx Pharmaceuticals, Inc. | -0.6631 |
| Cannabis Global, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | -0.1113 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.37M |
| Total Expenses (Quarterly) | 22.37M |
| Enterprise Value | -55.67M |
| Earnings Yield | -128.5% |
| Normalized Earnings Yield | -124.21 |